While most patients with obsessive-compulsive disorder (OCD) respond to serotonin re-uptake inhibitors (SRIs), augmentation strategies are used in the refractory subgroup [1]. While a recent report...
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2000) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: